E. Simard, E. Ward, R. Siegel, and A. Jemal, Cancers with increasing incidence trends in the United States: 1999 through 2008, CA: A Cancer Journal for Clinicians, vol.37, issue.RR-16, pp.118-128, 2008.
DOI : 10.3322/caac.20141

L. Rahib, B. Smith, R. Aizenberg, A. Rosenzweig, J. Fleshman et al., Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States, Cancer Research, vol.74, issue.11, pp.2913-2934, 2011.
DOI : 10.1158/0008-5472.CAN-14-0155

K. Palucka and J. Banchereau, Dendritic-Cell-Based Therapeutic Cancer Vaccines, Immunity, vol.39, issue.1, pp.38-48, 2013.
DOI : 10.1016/j.immuni.2013.07.004

URL : http://doi.org/10.1016/j.immuni.2013.07.004

J. Cremer, I. Galon, J. Tartour, E. Zitvogel, L. Kroemer et al., Trial watch: Dendritic cell-based interventions for cancer therapy, Oncoimmunology, vol.2, p.25771, 2013.

L. Dodson, W. Hawkins, and P. Goedegebuure, Potential targets for pancreatic cancer immunotherapeutics, Immunotherapy, vol.3, issue.4, pp.517-554, 2011.
DOI : 10.2217/imt.11.10

T. Freire, R. Lo-man, S. Bay, and C. Leclerc, Tn Glycosylation of the MUC6 Protein Modulates Its Immunogenicity and Promotes the Induction of Th17-biased T Cell Responses, Journal of Biological Chemistry, vol.286, issue.10, pp.7797-7811, 2011.
DOI : 10.1074/jbc.M110.209742

O. Figarella, C. Escribano, M. Lombardo, and D. , Human fetoacinar pancreatic protein: an oncofetal glycoform of the normally secreted pancreatic bile-salt-dependent lipase, Biochem Journal, vol.289, pp.609-615, 1993.

@. A. Silvy, F. Bernard, J. Lombardo, D. Beraud, E. Olive et al., A novel tumor-associated pancreatic glycoprotein is internalized by human dendritic cells and induces their maturation, Journal of Immunology. www.impactjournals.com/oncotarget Current Opinion in Immunology, vol.18620, pp.4067-77558, 2008.

J. Tel, S. Anguille, C. Waterborg, E. Smits, and C. Figdor, Tumoricidal activity of human dendritic cells, Trends in Immunology, vol.35, issue.1, pp.38-46, 2014.
DOI : 10.1016/j.it.2013.10.007

R. Prins, S. Odesa, and L. Liau, Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model, Cancer Research, vol.63, pp.8487-91, 2003.

H. Kim, Y. Choo, T. Koo, S. Bang, T. Oh et al., Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer, Immunology Letters, vol.103, issue.2, pp.142-190, 2006.
DOI : 10.1016/j.imlet.2005.10.021

C. Bauer, F. Bauernfeind, A. Sterzik, M. Orban, M. Schnurr et al., Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model, Gut, vol.56, issue.9, pp.1275-82, 2007.
DOI : 10.1136/gut.2006.108621

G. Eberl, P. Brawand, and H. Macdonald, Selective bystander proliferation of memory CD4+ and CD8 + T cells, pp.4305-4316, 2000.

L. Lanier, L. Yokoyama, W. Ugolini, and S. , Innate or adaptive immunity? The example of natural killer cells, Science, vol.331, pp.44-53, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00611585

B. Carreno, M. Becker-hapak, A. Huang, M. Chan, A. Alyasiry et al., IL-12p70???producing patient DC vaccine elicits Tc1-polarized immunity, Journal of Clinical Investigation, vol.123, issue.8, pp.3383-94, 2013.
DOI : 10.1172/JCI68395DS1

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726168

J. Wargo and L. Schumacher, Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells, Cancer Gene Therapy, vol.30, issue.6, pp.516-543, 2005.
DOI : 10.1038/sj.cgt.7700818

J. Boudreau, B. Bridle, K. Stephenson, K. Jenkins, J. Brunellière et al., Recombinant Vesicular Stomatitis Virus Transduction of Dendritic Cells Enhances Their Ability to Prime Innate and Adaptive Antitumor Immunity, Molecular Therapy, vol.17, issue.8, pp.1465-72, 2009.
DOI : 10.1038/mt.2009.95

A. Ribas and J. Wargo, Enhanced Tumor Responses to Dendritic Cells in the Absence of CD8-Positive Cells, The Journal of Immunology, vol.172, issue.8, pp.4762-69, 2004.
DOI : 10.4049/jimmunol.172.8.4762

K. Shimizu and S. Fujii, DC therapy induces long-term Immunology, pp.457-68, 2009.

J. Boudreau, K. Stephenson, F. Wang, K. Jenkins, J. Brunellière et al., IL- 15 and type I interferon are required for activation of Cancer Research, pp.2497-506, 2011.

K. Candido, K. Shimizu, J. Mclaughlin, R. Kunkel, J. Fuller et al., Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents, Cancer Research, vol.61, pp.228-264, 2001.

S. Hingorani, L. Wang, A. Multani, C. Combs, T. Deramaudt et al., Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice, Cancer Cell, vol.7, issue.5, pp.469-83, 2005.
DOI : 10.1016/j.ccr.2005.04.023

A. Blackford, G. Parmigiani, T. Kensler, W. Eshleman, J. Goggins et al., Genetic Mutations Associated with Cigarette Smoking in Pancreatic Cancer, Cancer Research, vol.69, issue.8, pp.3681-3688, 2009.
DOI : 10.1158/0008-5472.CAN-09-0015

S. Seelig, B. Burkert, A. Chromik, A. Tannapfel, U. Seelig et al., Pancreatic Resections for Advanced M1-Pancreatic Carcinoma: The Value of Synchronous Metastasectomy, HPB Surgery, vol.25, issue.6, pp.579-672, 2010.
DOI : 10.1067/msy.2002.128615

W. Aerts, R. Topal, and B. , Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma, European Journal of Surgical Oncology, vol.35, pp.600-604, 2009.

I. Melero, G. Gaudernack, W. Gerritsen, C. Huber, I. Parmiani et al., Therapeutic vaccines for cancer: an Oncology, pp.509-533, 2014.

S. Muramatsu, S. Steinman, and R. , Generation of large numbers of dendritic cells from mouse bone marrow @@@@@@@@@@@@@@@@@@@@@@@ colony-stimulating factor, Journal of Experimental Oncotarget